secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunovant, Inc. (IMVT)
CIK:        0001764013
Form:       8-K
Filed at:   2021-07-13T23:59:59+00:00
Accession:  0001764013-21-000058
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunovant CFO Pamela Yanchik Connealy resigns effective July 16; transition consulting through Sept 9
--------------------------------------------------------------------------------

- CFO Pamela Yanchik Connealy resigned effective July 16, 2021; no reason given.
- She will provide transition consulting services through expected annual meeting (~Sept 9, 2021) at $375/hour.
- Consulting agreement filed as Exhibit 10.1; she reports to CEO Peter Salzmann.
- No immediate replacement for CFO named; transition period ends at annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764013/000176401321000058/0001764013-21-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764013/000176401321000058/imvt-20210707.htm
  HTML page:      https://secwatch.observer/filing/0001764013-21-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer